A recent study suggests that the perceived benefits of microdosing psychedelics like psilocybin for depression may be largely due to placebo effects. The research found that participants who believed they were microdosing, but were actually given a placebo, reported similar improvements in mood and mental health as those taking the actual substances. The study highlights the powerful role of expectation in mental health treatments and calls for more rigorous, controlled trials to separate pharmacological effects from psychological ones. Read the full article at: https://www.wired.com/story/microdosing-for-depression-appears-to-work-about-as-well-as-drinking-coffee/